Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | IT (& TMT) • Media • BioTech • Hardware (& Manufacturing) • Energy • HealthTech (& Fitness) • Logistics (& Distribution) • Material Science • Medical Devices (& Hospital Services) |
Stages | Expansion, MBO/LBO, Acquisition, Recapitalization, Corporate Divestiture, Ownership Transition |
Investing | United States • United Kingdom • India • China • Israel • Europe • Asia • Ireland |
Investment Range | $2,000,000 - $5,000,000 |
Assets Under Management | $55,000,000 |
Stonehenge Growth Capital, LLC is a private equity fund that specializes in a range of investment activities aimed at fostering growth and enabling smooth transitions in various industries. With an assertive role in the market, their expertise lies primarily in equity investments, and they engage in financial endeavors such as expansion, management buyouts (MBO)/leveraged buyouts (LBO), acquisitions, recapitalizations, corporate divestitures, and ownership transitions. They maintain an investment approach that applies a minimum cap of $2,000,000 and a maximum of $5,000,000, catering to middle-market companies looking to bolster their operations. Stonehenge Growth Capital boasts assets under management valued at $55,000,000, indicative of its considerable influence and the level of trust placed in its capabilities by stakeholders. They focus on sectors that include Information Technology (IT), Media, BioTech, Hardware, Manufacturing, Energy, HealthTech, Fitness, Logistics, Distribution, Material Science, and Medical Devices. Their investment philosophy marries hands-on involvement with a dedication to best business practices, ensuring that portfolio companies benefit from disciplined budgeting, governance, compliance, and focus on key performance indicators and metrics. With an appreciation for scientific innovation and advanced technologies, they also facilitate effective communication between the technical personnel and financial stakeholders, thereby creating a cohesive environment that enhances both scientific advancement and viable economic returns. The fund is headquartered in New York City at 10 East 40th Street, Suite 3210, and its approach is designed to support companies in realizing their full potential while often providing more than just capital through its flexible investment structures.